These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Rivastigmine for Alzheimer's disease. Birks J; Grimley Evans J; Iakovidou V; Tsolaki M; Holt FE Cochrane Database Syst Rev; 2009 Apr; (2):CD001191. PubMed ID: 19370562 [TBL] [Abstract][Full Text] [Related]
16. Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group. Rogers SL; Doody RS; Mohs RC; Friedhoff LT Arch Intern Med; 1998 May; 158(9):1021-31. PubMed ID: 9588436 [TBL] [Abstract][Full Text] [Related]
17. Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review. Clegg A; Bryant J; Nicholson T; McIntyre L; De Broe S; Gerard K; Waugh N Health Technol Assess; 2001; 5(1):1-137. PubMed ID: 11262420 [TBL] [Abstract][Full Text] [Related]